Condensation reactions of monomeric hydroxo palladium complexes with active methyl and methylene compounds

Heating a suspension of the monomeric hydroxo palladium complex of the type [Pd(N-N)(C(6)F(5))(OH)](N-N = bipy, Me(2)bipy, phen or tmeda) in methylketone (acetone or methylisobutylketone) under reflux affords the corresponding ketonyl palladium complex [Pd(N-N)(C(6)F(5))(CH(2)COR)]. On the other hand, the reaction of the hydroxo palladium complexes [Pd(N-N)(C(6)F(5))(OH)](N-N = bipy, phen or tmeda) with diethylmalonate or malononitrile yields the C-bound enolate palladium complexes [Pd(N-N)(CHX(2))(C(6)F(5))](X = CO(2)Et or CN), and the reaction of [Pd(N-N)(C(6)F(5))(OH)](N-N = bipy or phen) with nitromethane gives the nitromethyl palladium complexes [Pd(N-N)(CH(2)NO(2))(C(6)F(5))]. [Pd(tmeda)(C(6)F(5))(OH)] catalyses the cyclotrimerization of malononitrile. The crystal structures of [Pd(bipy)(C(6)F(5))(CH(2)COMe)].1/2Me(2)CO, [Pd(tmeda)(C(6)F(5))[CH(CO(2)Et)(2)]], [Pd(tmeda)(C(6)F(5))[CH(CN)(2)]] and [Pd(tmeda)(C(6)F(5))(CH(2)NO(2))].1/2CH(2)Cl(2) have been established by X-ray diffraction.     

Insertion reactions into Pd[bond]O and Pd[bond]N bonds: preparation of alkoxycarbonyl,carbonato, carbamato,thiocarbamate, and thioureide complexes of palladium(II)

Mononuclear palladium hydroxo complexes of the type [Pd(N[bond]N)(C(6)F(5))(OH)] [(N[bond]N = 2,2'-bipyridine (bipy), 4,4'-dimethyl-2,2'-bipyridine (Me(2)bipy), 1,10-phenanthroline (phen), or N,N,N',N'-tetramethylethylenediamine (tmeda)] have been prepared by reaction of [Pd(N[bond]N)(C(6)F(5))(acetone)]ClO(4) with KOH in methanol. These hydroxo complexes react, in methanol, with CO (1 atm, room temperature) to yield the corresponding methoxycarbonyl complexes [Pd(N[bond]N)(C(6)F(5))(CO(2)Me)]. Similar alkoxycarbonyl complexes [Pd(N[bond]N)(C(6)F(5))(CO(2)R)] (N[bond]N = bis(3,5-dimethylpyrazol-1-yl)methane); R = Me, Et, or (i)Pr) are obtained when [Pd(N[bond]N)(C(6)F(5))Cl] is treated with KOH in the corresponding alcohol ROH and CO is bubbled through the solution. The reactions of [Pd(N[bond]N)(C(6)F(5))(OH)] (N[bond]N = bipy or Me(2)bipy) with CO(2), in tetrahydrofuran, lead to the formation of the binuclear carbonate complexes [(N[bond]N)(C(6)F(5))Pd(mu-eta(2)-CO(3))Pd(C(6)F(5))(N[bond]N)]. Complexes [Pd(N[bond]N)(C(6)F(5))(OH)] react in alcohol with PhNCS to yield the corresponding N-phenyl-O-alkylthiocarbamate complexes [Pd(N[bond]N)(C(6)F(5))[SC(OR)NPh]]. Similarly, the reaction of [Pd(bipy)(C(6)F(5))(OH)] with PhNCO in methanol gives the N-phenyl-O-methylcarbamate complex [Pd(bipy)(C(6)F(5))[NPhC(O)OR]]. The reactions of [(N[bond]N)Pd(C(6)F(5))(OH)] with PhNCS in the presence of Et(2)NH yield the corresponding thioureidometal complexes [Pd(N[bond]N)(C(6)F(5))[NPhCSNR(2)]]. The crystal structures of [Pd(tmeda)(C(6)F(5))(CO(2)Me)], [Pd(2)(Me(2)bipy)(2)(C(6)F(5))(2)(mu-eta(2)-CO(3))].2CH(2)Cl(2), and [Pd(tmeda)(C(6)F(5))[SC(OMe)NPh]] have been determined.     

Pentafluorophenyl imidato palladium(II) complexes: catalysts for Suzuki cross-coupling reactions

Novel N-bonded imidato complexes of general formula [Pd(N-N)(C6F5)(imidate)](imidate = maleimidate, succinimidate or phthalimidate; N-N = 2,2'-bipyridine (bipy), 4,4'-dimethyl-2,2'-bipyridine (Me2bipy) or N,N,N',N'-tetramethylethylenediamine (tmeda)), [NBu4][Pd(C6F5)(H2O)(succinimidate)2] and [NBu4][Pd(C6F5)(L)(succinimidate)2](L = PPh3 or t-BuNC) have been synthesised. These complexes are air-, light- and moisture-stable. The crystal structures of [Pd(tmeda)(C6F5)(maleimidate)].H2O.0.5CHCl3, [NBu4][Pd(C6F5)(H2O)(succinimidate)2].H2O and [NBu4][Pd(C6F5)(t-BuNC)(succinimidate)2].2H2O have been determined by X-ray diffraction. Many of these new complexes are shown to be active phosphine-free palladium catalysts/precatalysts for the Suzuki cross-coupling reactions of aryl bromides and aryl chlorides with phenylboronic acid.     

Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds

Palladium and platinum complexes with HmtpO (where HmtpO=4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine, an analogue of the natural occurring nucleobase hypoxanthine) of the types [M(dmba)(PPh3)(HmtpO)]ClO4[dmba=N,C-chelating 2-(dimethylaminomethyl)phenyl; M=Pd or Pt], [Pd(N-N)(C6F5)(HmtpO)]ClO4[N-N=2,2'-bipyridine (bpy), 4,4'-dimethyl-2,2'-bipyridine (Me2bpy), or N, N, N', N'-tetramethylethylenediamine (tmeda)] and cis-[M(C6F5)2(HmtpO)2] (M=Pd or Pt) (head-to-head atropisomer in the solid state) have been obtained. Pd(II) and Pt(II) complexes with the anion of HmtpO of the types [Pd(tmeda)(C6F5)(mtpO)], [Pd(dmba)(micro-mtpO)] 2, and [NBu4]2[M(C6F5)2(micro-mtpO)]2(M=Pd or Pt) have been prepared starting from the corresponding hydroxometal complexes. Complexes containing simultaneously both the neutral HmtpO ligand and the anionic mtpO of the type [NBu4][M(C6F5)2(HmtpO)(mtpO)] (M=Pd or Pt) have been also obtained. In these mtpO-HmtpO metal complexes, for the first time, prototropic exchange is observed between the two heterocyclic ligands. The crystal structures of [Pd(dmba)(PPh 3)(HmtpO)]+, cis-[Pt(C6F5)2(HmtpO)2].acetone, [Pd(C6F5)(tmeda)(mtpO)].2H2O, [Pd(dmba)(micro-mtpO)]2, [NBu4]2[Pd(C6F5)2(micro-mtpO)]2.CH2Cl2.toluene, [NBu4]2[Pt(C6F5)2(micro-mtpO)](2).0.5(toluene), and [NBu4][Pt(C6F5)2(mtpO)(HmtpO)] have been established by X-ray diffraction. Values of IC50 were calculated for the new platinum complexes cis-[Pt(C6F5)2(HmtpO)2] and [Pt(dmba)(PPh3)(HmtpO)]ClO4 against a panel of human tumor cell lines representative of ovarian (A2780 and A2780 cisR), lung (NCI-H460), and breast cancers (T47D). At 48 h incubation time, both complexes were about 8-fold more active than cisplatin in T47D and show very low resistance factors against an A2780 cell line, which has acquired resistance to cisplatin. The DNA adduct formation of cis-[Pt(C6F5)2(HmtpO)2] and [Pt(dmba)(PPh3)(HmtpO)]ClO4 was followed by circular dichroism and electrophoretic mobility. Atomic force microscopy images of the modifications caused by these platinum complexes on plasmid DNA pB R322 were also obtained.     

Palladium(II) and platinum(II) organometallic complexes with the model nucleobase anions of thymine, uracil, and cytosine: antitumor activity and interactions with DNA of the platinum compounds

Pd(II) and Pt(II) complexes with the anions of the model nucleobases 1-methylthymine (1-MethyH), 1-methyluracil (1-MeuraH), and 1-methylcytosine (1-MecytH) of the types [Pd(dmba)(mu-L)]2 [dmba = N,C-chelating 2-((dimethylamino)methyl)phenyl; L = 1-Methy, 1-Meura or 1-Mecyt] and [M(dmba)(L)(L')] [L = 1-Methy or 1-Meura; L' = PPh(3) (M = Pd or Pt), DMSO (M = Pt)] have been obtained. Palladium complexes of the types [Pd(C6F5)(N-N)(L)] [L = 1-Methy or 1-Meura; N-N = N,N,N',N'-tetramethylethylenediamine (tmeda), 2,2'-bipyridine (bpy), or 4,4'-dimethyl-2,2'-bipyridine (Me2bpy)] and [NBu4][Pd(C6F5)(1-Methy)2(H2O)] have also been prepared. The crystal structures of [Pd(dmba)(mu-1-Methy)]2, [Pd(dmba)(mu-1-Mecyt)]2.2CHCl3, [Pd(dmba)(1-Methy)(PPh3)].3CHCl3, [Pt(dmba)(1-Methy)(PPh3)], [Pd(tmeda)(C6F5)(1-Methy)], and [NBu4][Pd(C6F5)(1-Methy)2(H2O)].H2O have been established by X-ray diffraction. The DNA adduct formation of the new platinum complexes synthesized was followed by circular dichroism and electrophoretic mobility. Atomic force microscopy images of the modifications caused by the platinum complexes on plasmid DNA pBR322 were also obtained. Values of IC50 were also calculated for the new platinum complexes against the tumor cell line HL-60. All the new platinum complexes were more active than cisplatin (up to 20-fold in some cases).     

Reactivity of molybdenum and rhenium hydroxo-carbonyl complexes toward organic electrophiles

The hydroxo compounds [Re(OH)(CO)(3)(N-N)] (N-N=bipy, 2 a; Me(2)-bipy, 2 b) were prepared in a biphasic H(2)O/CH(2)Cl(2) medium by reaction of [Re(OTf)(CO)(3)(N-N)] with KOH. In contrast, when anhydrous CH(2)Cl(2) was used, the binuclear hydroxo-bridged compound [[Re(CO)(3)(bipy)](2)(mu-OH)]OTf (3-OTf) was obtained. Compound [Re(OH)(CO)(3)(Me(2)-bipy)] (2 b) reacted with phenyl acetate or vinyl acetate to afford [Re(OAc)(CO)(3)(Me(2)-bipy)] (4) and phenol or acetaldehyde, respectively. The reactions of [Mo(OH)(eta(3)-C(3)H(4)-Me-2)(CO)(2)(phen)] (1), 2 a, and 2 b toward several unsaturated organic electrophiles were studied. The reaction of 1 with (p-tolyl)isocyanate afforded an adduct of N,N'-di(p-tolyl)urea and the carbonato-bridged compound [[Mo(eta(3)-C(3)H(4)-Me-2)(CO)(2)(phen)](2)(mu-eta(1)(O),eta(1)(O)-CO(3))] (5). In contrast, the reaction of 2 a with phenylisocyanate afforded [Re(OC(O)NHPh)(CO)(3)(bipy)] (6); this results from formal PhNCO insertion into the O-H bond. On the other hand, compounds [Mo[SC(O)NH(p-tolyl)](eta(3)-C(3)H(4)-Me-2)(CO)(2)(phen)] (7), [Re[SC(O)NH(p-tolyl)](CO)(3)(Me(2)-bipy)] (8 a), and [Re[SC(O)NHEt](CO)(3)(Me(2)-bipy)] (8 b) were obtained by reaction of 1 or 2 b with the corresponding alkyl or aryl isothiocyanates. In those cases, RNCS was inserted into the M-O bond. The reactions of 1, 2 a, and 2 b with dimethylacetylenedicarboxylate (DMAD) gave the complexes [Mo[C(OH)-C(CO(2)Me)C(CO(2)Me)-O](eta(3)-C(3)H(4)-Me-2)(CO)(phen)] (9) and [Re[C(OH)C(CO(2)Me)C(CO(2)Me)O](CO)(2)(N-N)] (N-N=bipy, 10 a; Me(2)-bipy, 10 b). The molecules of these compounds contain five-membered metallacycles that are the result of coupling between the hydroxo ligand, DMAD, and one of the CO ligands. The new compounds were characterized by a combination of IR and NMR spectroscopy, and for [[Re(CO)(3)(bipy)(2)(mu-OH)]BF(4) (3-BF(4)), 4, 5, 6, 7, 8 b, 9, and 10 b, also by means of single-crystal X-ray diffraction.     

New palladium(II) and platinum(II) complexes with the model nucleobase 1-methylcytosine: antitumor activity and interactions with DNA

Palladium and platinum complexes with the model nucleobase 1-methylcytosine (1-Mecyt) of the types [Pd(N-N)(C6F5)(1-Mecyt)]ClO4 [N-N = bis(3,5-dimethylpyrazol-1-yl)methane (bpzm), bis(pyrazol-1-yl)methane (bpzm), N,N,N',N'-tetramethylethylenediamine (tmeda), or 2,2'-bipyridine (bpy)] and [M(dmba)(L')(1-Mecyt)]ClO4 [dmba = N,C-chelating 2-(dimethylaminomethyl)phenyl; L' = PPh(3) (M = Pd or Pt), DMSO (M = Pt)] have been obtained. Palladium and platinum complexes of the types cis-[M(C6F5)2(1-Mecyt)2] (M = Pd or Pt) and cis-[Pd(L')(C6F5)(1-Mecyt)2]ClO4 (L' = PPh(3) or t-BuNC) have also been prepared. The crystal structures of [Pd(bpzm)(C6F5)(1-Mecyt)]ClO4, [Pt(dmba)(DMSO)(1-Mecyt)]ClO4, cis-[Pd(C6F5)2(1-Mecyt)2], and cis-[Pd(t-BuNC)(C6F5)(1-Mecyt)2]ClO4 have been established by X-ray diffraction. There is extensive hydrogen bonding (N-H...O, C-H...F or C-H...O) in all the compounds. There are also intermolecular pi-pi interactions between pyrimidine rings of adjacent chains in [Pd(C6F5)2(1-Mecyt)2]. DNA adduct formation of the new complexes synthesized was followed by circular dichroism and electrophoretic mobility. Atomic force microscopy images of the modifications caused by the complexes on plasmid DNA pBR322 were also obtained. Values of IC(50) were also calculated for the new complexes against the tumor cell line HL-60. At a short incubation time (24 h) almost all new complexes were more active than cisplatin.     

Synthesis and characterization of monomeric siloxo palladium(II) complexes: crystal structure of [Pd(tmeda)(C6F5)(OSiPh3)]

Mononuclear palladium-hydroxo complexes of the type [Pd(N-N)(C₆F₅)(OH)] [(N-N)=2,2^′-bipyridine (bipy), 4,4^′-dimethyl-2,2^′-bipyridine (Me₂bipy), or N,N,N^′,N^′-tetramethylethylenediamine (tmeda)] react with silanols HOSiR₃ in toluene giving the corresponding siloxo complexes [Pd(N-N)(C₆F₅)(OSiR₃)]. The X-ray crystal structure of [Pd(tmeda)(C₆F₅)(OSiPh₃)] has been determined. In one of the two molecules in the asymmetric unit there is an intramolecular interaction by phenyl-pentafluorophenyl π-stacking.     

Molecular triangle of palladium(II) and its anion binding properties

The ligand 4(3H)-pyrimidone (Hpm) forms the complexes trans-[PdCl(2)(Hpm)(2)] and [Pd(PP)(Hpm)(2)](CF(3)SO(3))(2) (PP = Ph(2)PCH(2)PPh(2) or Ph(2)P(CH(2))(3)PPh(2)), with the neutral ligand (Hpm), and a bowl-like molecular triangle, [(Pd(bu(2)bipy)(mu-pm))(3)](3+) (bu(2)bipy = 4,4'-di-tert-butyl-2,2'-bipyridine), with the deprotonated ligand (pm). This triangular complex acts as a host for binding of several anionic guests.     

The metalla-Pinner reaction between Pt(IV)-bound nitriles and alkylated oxamic and oximic forms of hydroxamic acids

The nitrile ligands in the platinum(IV) complexes trans-[PtCl4(RCN)2] (R=Me, Et, CH2Ph) and cis/trans-[PtCl4(MeCN)(Me2SO)] are involved in a metalla-Pinner reaction with N-methylbenzohydroxamic acid (N-alkylated form of hydroxamic acid, hydroxamic form; F1), PhC(=O)N(Me)OH, to achieve the imino species [PtCl4[NH=C(R)ON(Me)C(=O)Ph]2 (1-3) and [PtCl4[NH=C(Me)ON(Me)C(=O)Ph](Me2SO)] (7), respectively. Treatment of trans-[PtCl4(RCN)2] (R=Me, Et) and cis/trans-[PtCl4(MeCN)(Me2SO)] with the O-alkylated form of a hydroxamic acid (hydroximic form), i.e. methyl 2,4,6-trimethylbenzohydroximate, 2,4,6-(Me3C6H2)C(OMe)=NOH (F2A), allows the isolation of [PtCl4[NH=C(R)ON=C(OMe)(2,4,6-Me3C6H2)]2] (5, 6) and [PtCl4[NH=C(Me)ON=C(OMe)(2,4,6-Me3C6H2)](Me2SO)] (8), correspondingly. In accord with the latter reaction, the coupling of nitriles in trans-[PtCl4(EtCN)2] with methyl benzohydroximate, PhC(OMe)=NOH (F2B), gives [PtCl4[NH=C(Et)ON=C(OMe)Ph]2] (4). The addition proceeds faster with the hydroximic F2, rather than with the hydroxamic form F1. The complexes 1-8 were characterized by C, H, N elemental analyses, FAB+ mass-spectrometry, IR, 1H and 13C[1H] NMR spectroscopies. The X-ray structure determinations have been performed for both hydroxamic and hydroximic complexes, i.e. 2 and 6, indicating that the imino ligands are mutually trans and they are in the E-configuration.     

Role of cyclometalation in controlling the rates of ligand substitution at platinum(II) complexes

The rates of chloride for triphenylphosphine substitution have been measured in dichloromethane for a series of cyclometalated [Pt(N-N-C)Cl] complexes containing a number of terdentate N-N-C anionic ligands, derived from deprotonated alkyl-, phenyl-, and benzyl-6-substituted 2,2'-bipyridines. These rates have been compared with those of the corresponding [Pt(N-N)(C)Cl] (N-N = 2,2'-bipyridine; C = CH3 or C6H5) complexes having the same set of donor atoms but less constrained arrangements of the ligands. The reactions of the cyclometalated compounds occur as a single-stage conversion from the substrate to the ionic pair [Pt(N-N-C)(PPh3)]Cl products. There is no evidence by 1H and 31P(1H) NMR spectroscopy for the formation of other Pt(II) species or of concurrent ring-opening processes. In contrast, in the monoalkyl- or monoaryl-2,2'-bipyridine complexes, chloride substitution is followed by subsequent slower processes which involve the detachment of one arm of the chelated 2,2'-bipyridine, fast cis to trans isomerization of the cis-[Pt(PPh3)2(eta 1-bipy)(R)]+ transient intermediate, and, eventually, the release of free bipy, yielding trans-[Pt(PPh3)2(R)Cl] (R = Me or Ph). All reactions are first-order with respect to complex and phosphine concentration, obeying the simple rate law kobsd = k2[PPh3]. The values of the second-order rate constant k2 do not seem particularly sensitive to the nature of the bonded organic moiety (alkyl or aryl), to its structure (cyclometalated or not), to the size of the ring, or to the number of alkyl substituents on it. The effects are those foreseen on the basis of an associative mode of activation. The only exception to this pattern of behavior is constituted by the complex [Pt(bipy phi-H)Cl] (bipy phi = 6-phenyl-2,2'-bipyridine), which features a significant rate enhancement with respect to the analogue [Pt(bipy)(Ph)Cl] complex. The results of this work, together with those of a previous paper, suggest that there is not a specific role of cyclometalation in controlling the reactivity, unless an in-plane aryl ring becomes part of the pi-acceptor system of the chelated 2,2-bipyridine, behaving as a cyclometalated analogue of the nitrogen terdentate 2,2':6',2"-terpyridine.     

Insertion of unsaturated organic electrophiles into molybdenumbond-alkoxide and rheniumbond-alkoxide bonds of neutral,stable carbonyl complexes

Alkoxo complexes [Re(OR)(CO)(3)(N-N)] (R=Me, Et, tBu; N-N=2,2'-bipyridine (bipy), 4,4'-dimethyl-2,2'bipyridine (bipy'), 1,10-phenanthroline (phen)) and [M(OMe)(eta(3)-allyl)(CO)(2)(phen)] (M=Mo, W) have been synthesized in good yields and using mild conditions by the reaction of sodium alkoxides with [Re(OTf)(CO)(3)(N-N)] and [MCl(eta(3)-allyl)(CO)(2)(phen)] precursors. These have been characterized by IR and NMR spectroscopy as well as by X-ray diffraction for [W(OMe)(eta(3)-allyl)(CO)(2)(phen)] (10). The reactions of the molybdenum and rhenium alkoxo complexes with isocyanates, R'NCO, yield [L(n)M[N(R')C(O)OR]] complexes; the carbamate ligand, which results from an R'NCO insertion into the Mbond;OR bond, is monodentate through the nitrogen atom. The solid-state structures of Mo and Re examples have been determined by X-ray diffraction. The geometry around the carbamate nitrogen of these compounds is planar, and the distances indicate delocalization of the nitrogen lone pair involving mainly the carbonyl groups. Experiments carried out with the Re complexes showed that aryl isocyanates are more reactive than their alkyl counterparts, and that bulky R' groups led to slow rates of insertion. Insertion reactions were also observed with isothiocyanates, although here it is the Sbond;C bond that inserts into the Mbond;OR bond, and the resulting ligand is bound to the metal by sulfur. Competition experiments with the Re compounds indicate that isocyanates are more reactive than isothiocyanates towards the Rebond;OR bonds. Tetracyanoethylene inserts into the Rebond;OMe bond of [Re(OMe)(CO)(3)(bipy')], forming a complex with a 2-methoxytetracyanoethyl ligand; the structure of which was determined by X-ray diffraction. The formation of the xanthato complex [Re(SC(S)OtBu)(CO)(3)(bipy)] (20) by reaction of [Re(OTf)(CO)(3)(bipy)] with CS(2) and NaOtBu, but not by the reaction of CS(2) and [Re(OtBu)(CO)(3)(bipy)] (5 a), suggests that the insertion reactions do not take place by ionization of the alkoxo complexes to give the free alkoxide ion.     

Osmabenzenes from the reactions of a dicationic osmabenzyne complex

Treatment of the osmabenzyne Os([triple bond]CC(SiMe(3))=C(Me)C(SiMe(3))=CH)Cl(2)(PPh(3))(2) (1) with 2,2'-bipyridine (bipy) and thallium triflate (TlOTf) produces the thermally stable dicationic osmabenzyne [Os([triple bond]CC(SiMe(3))=C(Me)C(SiMe(3))=CH)(bipy)(PPh(3))(2)](OTf)(2) (2). The dicationic osmabenzyne 2 reacts with ROH (R = H, Me) to give osmabenzene complexes [Os(=C(OR)CH=C(Me)C(SiMe(3))=CH)(bipy)(PPh(3))(2)]OTf, in which the metallabenzene ring deviates significantly from planarity. In contrast, reaction of the dicationic complex 2 with NaBH(4) produces a cyclopentadienyl complex, presumably through the osmabenzene intermediate [Os(=CHC(SiMe(3))=C(Me)C(SiMe(3))=CH)(bipy)(PPh(3))(2)]OTf. The higher thermal stability of [Os(=C(OR)CH=C(Me)C(SiMe(3))=CH)(bipy)(PPh(3))(2)]OTf relative to [Os(=CHC(SiMe(3))=C(Me)C(SiMe(3))=CH)(bipy)(PPh(3))(2)]OTf can be related to the stabilization effect of the OR groups on the metallacycle. A theoretical study shows that conversion of the dicationic osmabenzyne complex [Os([triple bond]CC(SiMe(3))=C(Me)C(SiMe(3))=CH)(bipy)(PPh(3))(2)](OTf)(2) to a carbene complex by reductive elimination is thermodynamically unfavorable. The theoretical study also suggests that the nonplanarity of the osmabenzenes [Os(=C(OR)CH=C(Me)C(SiMe(3))=CH)(bipy)(PPh(3))(2)]OTf is mainly due to electronic reasons.     

Luminescent piano-stool complexes incorporating 1-(4-cyanophenyl)imidazole: synthesis, spectral, and structural studies

Three novel luminescent piano-stool arene ruthenium complexes of general formula [(eta(6)-arene)RuCl(2)(CPI)] (eta(6)-arene = benzene, 1, p-cymene, 2, and hexamethylbenzene, 3; CPI=1-(4-cyanophenyl)imidazole were prepared. The molecular structures of 2 and 3 were determined crystallographically. Reaction of 1-3 with EPh(3) (E = P, As, or Sb) and N-N donor bases such as 2,2'-bipyridine and 1,10-phenanthroline afforded cationic mononuclear complexes of general formula [(eta(6)-arene)RuCl(CPI)(EPh(3))](+) (eta(6)-arene = C(6)H(6), E = P (1a), E = As (1b), E = Sb(1c); eta(6)-arene = C(10)H(14), E = P (2a), E = As (2b), E = Sb (2c); eta(6)-arene = C(6)Me(6), E = P (3a), E = As (3b), E = Sb (3c)) and [(eta(6)-arene)Ru(N-N)(CPI)](2+) (eta(6)-arene = C(6)H(6), N-N = bipy (1d), N-N = phen (1e); eta(6)-arene = C(10)H(14), N-N = bipy (2d), N-N = phen (2e); eta(6)-arene = C(6)Me(6), N-N = bipy (3d), N-N = phen (3e)). Molecular structures of 1a and 2a were also confirmed by X-ray crystallography. Structural studies of the complexes 2, 3, 1a, and 2a supported coordination of CPI through the imidazole nitrogen and the presence of a pendant nitrile group. Structural data also revealed stabilization of crystal packing in the complexes 2, 3, and 2a by C-H...X (X = Cl, F) type inter- and intramolecular interactions and in complex 1a by pi-pi stacking. Moreover, neutral homonuclear bimetallic complexes 2f,g were prepared by using complex 2 as a metallo-ligand, where CPI acts as a bridge between two metal centers. Emission spectra of the mononuclear complexes [(eta(6)-arene)RuCl(2)(CPI)] and its derivatives exhibited intense luminescence when excited in the metal to ligand charge-transfer band.     

Novel tailoring reaction for two adjacent coordinated nitriles giving platinum 1,3,5-triazapentadiene complexes

The tailoring reaction of the two adjacent nitrile ligands in cis-[PtCl(2)(RCN)(2)] (R = Me, Et, CH(2)Ph, Ph) and [Pt(tmeda)(EtCN)(2)][SO(3)CF(3)](2) (8.(OTf)(2); tmeda = N,N,N',N'-tetramethylethylenediamine) upon their interplay with N,N'-diphenylguanidine (DPG; NH=C(NHPh)(2)), in a 1:2 molar ratio gives the 1,3,5-triazapentadiene complexes [PtCl(2){NHC(R)NHC(R)=NH}] (1-4) and [Pt(tmeda){NHC(Et)NHC(Et)NH}][SO(3)CF(3)](2) (10.(OTf)(2)), respectively. In contrast to the reaction of 8.(OTf)(2) with NH=C(NHPh)(2), interaction of 8.(OTf)(2) with excess gaseous NH(3) leads to formation of the platinum(II) bis(amidine) complex cis-[Pt(tmeda){NH=C(NH(2))Et}(2)][SO(3)CF(3)](2) (9.(OTf)(2)). Treatment of trans-[PtCl(2)(RCN)(2)] (R = Et, CH(2)Ph, Ph) with 2 equiv of NH=C(NHPh)(2) in EtCN (R = Et) and CH(2)Cl(2) (R = CH(2)Ph, Ph) solutions at 20-25 degrees C leads to [PtCl{NH=C(R)NC(NHPh)=NPh}(RCN)] (11-13). When any of the trans-[PtCl(2)(RCN)(2)] (R = Et, CH(2)Ph, Ph) complexes reacts in the corresponding nitrile RCN with 4 equiv of DPG at prolonged reaction time (75 degrees C, 1-2 days), complexes containing two bidentate 1,3,5-triazapentadiene ligands, i.e. [Pt{NH=C(R)NC(NHPh)=NPh}(2)] (14-16), are formed. Complexes 14-16 exhibit strong phosphorescence in the solid state, with quantum yields (peak wavelengths) of 0.39 (530 nm), 0.61 (460 nm), and 0.74 (530 nm), respectively. The formulation of the obtained complexes was supported by satisfactory C, H, and N elemental analyses, in agreement with FAB-MS, ESI-MS, IR, and (1)H and (13)C{(1)H} NMR spectra. The structures of 1, 2, 4, 11, 13, 14, 9.(picrate)(2), and 10.(picrate)(2) were determined by single-crystal X-ray diffraction.     

W(bipy)(CN)6]-: a suitable metalloligand in the design of heterotrimetallic complexes. The first Cu(II)Ln(III)W(V) trinuclear complexes

The first 3d-4f-5d heterotrimetallic complexes using [W(V)(bipy)(CN)(6)](-) as a metalloligand were synthesized (bipy = 2,2'-bipyridine). The structural and magnetic properties of three [Cu(II)Ln(III)W(V)] complexes (Ln = Gd, Ho, Tb) are discussed.     

A systematic study on the synthesis, reactivity and structure of ortho-palladated aryloximes, including the first cyclopalladated aryloximato and iminoaryloxime complexes

Complexes [Pd{C,N-Ar{C(Me)=NOH}-2}(μ-Cl)](2) (1) with Ar = C(6)H(4), C(6)H(3)NO(2)-5 or C(6)H(OMe)(3)-4,5,6, were obtained from the appropriate oxime, Li(2)[PdCl(4)] and NaOAc. They reacted with neutral monodentate C-, P- or N-donor ligands (L), with [PPN]Cl ([PPN] = Ph(3)P=N=PPh(3)), with Tl(acac) (acacH = acetylacetone), or with neutral bidentate ligands N^N (tetramethylethylenediamine (tmeda), 4,4'-di-tert-butyl-2,2'-bipyridine ((t)Bubpy)) in the presence of AgOTf or AgClO(4) to afford complexes of the types [Pd{C,N-Ar{C(Me)=NOH}-2}Cl(L)] (2), [PPN][Pd{C,N-Ar{C(Me)=NOH}-2}Cl(2)] (3), [Pd{C,N-Ar{C(Me)=NOH}-2}(acac)] (4) or [Pd{C,N-Ar{C(Me)=NOH}-2}(N^N)]X (X = OTf, ClO(4)) (5), respectively. Complexes 1 reacted with bidentate N^N ligands in the presence of a base to afford mononuclear zwitterionic oximato complexes [Pd{C,N-Ar{C(Me)=NO}-2}(N^N)] (6). Dehydrochlorination of complexes 2 by a base yielded dimeric oximato complexes of the type [Pd{μ-C,N,O-Ar{C(Me)[double bond, length as m-dash]NO}-2}L](2) (7). The insertion of XyNC into the Pd-C(aryl) bond of complex 2 produced the mononuclear iminoaryloxime derivative [Pd{C,N-C(=NXy)Ar{C(Me)=NOH}-2}Cl(CNXy)] (8) which, in turn, reacted with [AuCl(SMe(2))] to give [Pd{μ-N,C,N-C(=NXy)Ar{C(Me)=NOH}-2}Cl](2) (9) with loss of XyNC. Some of these complexes are, for any metal, the first containing cyclometalated aryloximato (6, 7) or iminoaryloxime (8, 9) ligands. Various crystal structures of complexes of the types 2, 3, 6, 7, 8 and 9 have been determined.     

Gold-thallium supramolecular arrays with 4,4'-bipyridine. Solvent induction of luminescent networks

The reaction of [AuTl(C(6)Cl(5))(2)](n) with bipy at different molar ratios, solvents or crystallisation conditions affords a series of two- and three-dimensional luminescent complexes, [AuTl(C(6)Cl(5))(2)(bipy)(0.5)](n), [AuTl(C(6)Cl(5))(2)(bipy)](n), [[Tl(bipy)][Tl(bipy)(0.5)(THF)][Au(C(6)Cl(5))(2)](2)](n), [[Tl(bipy)][Tl(bipy)(0.5)(THF)][Au(C(6)Cl(5))(2)](2)xTHF](n) and [[AuTl(C(6)Cl(5))(2)(bipy)]x0.5toluene](n)(bipy = 4,4'-bipyridine; THF = tetrahydrofuran) all of them containing polymeric chains formed via unsupported Au...Tl interactions and bridging bipyridine ligands.     

Synthesis and Characterization of Monomeric Aryloxo Palladium Complexes of the Type [Pd(N–N)(OAr)(C6F5)]. Crystal Structure of [Pd(tmeda)(C6F5)(OC6H4NO2‐p)]

Mononuclear palladium‐hydroxo complexes of the type [Pd(N–N)(C₆F₅)(OH)][(N–N) = 2,2′‐bipyridine (bipy), 4,4′‐dimethyl‐2,2′‐bipyridine (Me₂bipy), 1,10‐phenantroline (phen) or N,N,N′,N′‐tetramethylethylenediamine (tmeda) react with phenols ArOH in tetrahydrofuran giving the corresponding aryloxo complexes [Pd(N–N)(C₆F₅)(OAr)]. Elemental analyses and spectroscopic (IR, ¹H and ¹⁹F) methods have been used to characterize the new complexes. The X‐ray crystal structure of [Pd(tmeda)(C₆F₅)(OC₆H₄NO₂‐p)] has been determined. In the crystal packing the planes defined by two C₆H₄ rings show a parallel orientation. There are also intermolecular C–H···F and C‐H···O hydrogen bonds.     

A bipyridyl thorium metallocene: synthesis, structure and reactivity

The synthesis, structure and reactivity of a new bipy thorium metallocene have been studied. The reduction of the thorium chloride metallocene [η(5)-1,3-(Me(3)C)(2)C(5)H(3)](2)ThCl(2) (1) with potassium graphite in the presence of 2,2'-bipyridine gives the purple bipy metallocene [η(5)-1,3-(Me(3)C)(2)C(5)H(3)](2)Th(bipy) (2) in good yield. Complex 2 has been fully characterized by various spectroscopic techniques, elemental analysis and X-ray diffraction analysis. Complex 2 reacts cleanly with trityl chloride, silver halides and diphenyl diselenide, leading to the halide metallocenes [η(5)-1,3-(Me(3)C)(2)C(5)H(3)](2)ThX(2) (X = Cl (1), Br (3), I (4)) and [η(5)-1,3-(Me(3)C)(2)C(5)H(3)](2)Th(F)(μ-F)(3)Th[η(5)-1,3-(Me(3)C)(2)C(5)H(3)](F)(bipy) (5), and selenido metallocene [η(5)-1,3-(Me(3)C)(2)C(5)H(3)](2)Th(SePh)(2) (6), in good conversions. In addition, 2 cleaves the C[double bond, length as m-dash]S bond of CS(2) to give the sulfido complex, [η(5)-1,3-(Me(3)C)(2)C(5)H(3)](2)ThS (7), which further undergoes an irreversible dimerization or nucleophilic addition with CS(2), leading to the dimeric sulfido complex {[η(5)-1,3-(Me(3)C)(2)C(5)H(3)](2)Th}(μ-S)(2) (8) and dimeric trithiocarbonate complex {[η(5)-1,3-(Me(3)C)(2)C(5)H(3)](2)Th}(μ-CS(3))(2) (10) in good yields, respectively.